Home Cart Sign in  
Chemical Structure| 57645-91-7 Chemical Structure| 57645-91-7

Structure of Clebopride malate
CAS No.: 57645-91-7

Chemical Structure| 57645-91-7

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Clebopride malate, with antiemetic and prokinetic properties, is a dopamine antagonist drug used to treat gastrointestinal dysfunction.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Clebopride malate

CAS No. :57645-91-7
Formula : C24H30ClN3O7
M.W : 507.96
SMILES Code : O=C(NC1CCN(CC2=CC=CC=C2)CC1)C3=CC(Cl)=C(N)C=C3OC.O=C(O)C(O)CC(O)=O
MDL No. :MFCD01743960

Safety of Clebopride malate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Clebopride malate

GPCR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
rat cerebellar membranes 103±15 nM(IC50) 90 min Clebopride displaced [3H]-FNM in rat cerebellar membranes with an IC50 of 103 nM, showing no selectivity for BDZ1 and BDZ2 binding sites. PMC1854082
rat hippocampal membranes 131±20 nM(IC50) 90 min Clebopride displaced [3H]-FNM in rat hippocampal membranes with an IC50 of 131 nM, showing no selectivity for BDZ1 and BDZ2 binding sites. PMC1854082
bovine cortical membranes 73 nM(IC50) 90 min Clebopride displaced [3H]-FNM in a concentration-dependent manner with an IC50 of 73 nM, indicating a competitive interaction with BDZ binding sites. PMC1854082

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.84mL

1.97mL

0.98mL

19.69mL

3.94mL

1.97mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories